CHDI Foundation
The CHDI Foundation, Inc., is a United States-based non-profit biomedical foundation that aims to "rapidly discover and develop drugs that delay or slow the progression of Huntington's disease", a neurodegenerative genetic disorder that affects muscle coordination and leads to cognitive decline.
| Founded | 2002 |
|---|---|
| Merger of | Renewable Foundation, Inc., Sweetfeet Foundation, Inc. |
| Type | 501(c)(3) Non-operating private foundation |
Tax ID no. | 73-1683871 |
| Focus | Huntington's disease research and drug development |
| Location |
|
| Method | Contract-based support of third-party research organizations |
President, Treasurer | Kenneth J. Slutsky |
Revenue (2014) | $224,410,566 |
| Expenses (2014) | $169,211,469 |
| Website | chdifoundation |
Formerly called | High Q Foundation |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.